# Protalix BioTherapeutics, Inc.: Form 8-K, filed Oct 19, 2017

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2017-10-19
- Accepted by EDGAR: Oct 19, 2017, 16:07 ET
- Period: 2017-10-17
- Accession: 0001144204-17-053226
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420417053226/tv477300_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420417053226/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420417053226/tv477300_8k.htm

Filed Oct 19, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-053226. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
